Core Points - The company has conducted a review of the first vesting list for the 2024 restricted stock incentive plan, confirming that the incentive objects meet the necessary qualifications as per relevant laws and regulations [1][2] - A total of 122 incentive objects have achieved the performance assessment requirements for the 2024 restricted stock incentive plan, with 3 individuals disqualified due to personal reasons [2] - The total number of restricted stocks to be vested for the eligible incentive objects is 210,000 shares, which complies with the legal and regulatory conditions [2] Summary by Sections - Incentive Plan Review - The board's remuneration and assessment committee has verified that the incentive objects do not fall under any disqualifying conditions as outlined in the relevant laws and regulations [1] - Performance Assessment - The individual performance results of the 122 incentive objects have met the assessment criteria, allowing them to qualify for the restricted stock vesting [2] - Vesting Details - The committee has approved the vesting of 210,000 shares of restricted stock to the eligible incentive objects, confirming that this action does not harm the interests of the company or its shareholders [2]
昊帆生物: 董事会薪酬与考核委员会关于2024年限制性股票激励计划首次授予部分第一个归属期归属名单的核查意见